Non-lethal outcomes of engaging regulated cell death pathways in cancer

被引：0
作者：
Halime Kalkavan
Sebastian Rühl
Jeremy J. P. Shaw
Douglas R. Green
机构：
[1] St Jude Children’s Research Hospital,Department of Immunology
[2] University Hospital Essen,West German Cancer Center, Department of Medical Oncology
[3] Partner Site University Hospital Essen,German Cancer Consortium (DKTK)
[4] T3 Pharmaceuticals AG,undefined
来源：
Nature Cancer | 2023年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Regulated cell death (RCD) is essential for successful systemic cancer therapy. Yet, the engagement of RCD pathways does not inevitably result in cell death. Instead, RCD pathways can take part in diverse biological processes if the cells survive. Consequently, these surviving cells, for which we propose the term ‘flatliners’, harbor important functions. These evolutionarily conserved responses can be exploited by cancer cells to promote their own survival and growth, with challenges and opportunities for cancer therapy.
引用
收藏
页码：795 / 806
页数：11
相关论文
共 279 条
[1]  
Lockshin RA(1964)Programmed cell death—II. Endocrine potentiation of the breakdown of the intersegmental muscles of silkmoths J. Insect Physiol. 10 643-649
[2]  
Williams CM(2020)The clearance of dead cells by efferocytosis Nat. Rev. Mol. Cell Biol. 21 398-414
[3]  
Boada-Romero E(2018)Viewing BCL2 and cell death control from an evolutionary perspective Cell Death Differ. 25 13-20
[4]  
Martinez J(2019)The molecular machinery of regulated cell death Cell Res. 29 347-364
[5]  
Heckmann BL(2011)Hallmarks of cancer: the next generation Cell 144 646-674
[6]  
Green DR(2008)Diagnosing and exploiting cancer’s addiction to blocks in apoptosis Nat. Rev. Cancer 8 121-132
[7]  
Strasser A(2016)A fate worse than death: apoptosis as an oncogenic process Nat. Rev. Cancer 16 539-548
[8]  
Vaux DL(2022)Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells Sci. Transl. Med. 14 eabc7480-275
[9]  
Tang D(2020)Detection of immunogenic cell death and its relevance for cancer therapy Cell Death Dis. 11 262-1129
[10]  
Kang R(2017)Dying cells actively regulate adaptive immune responses Nat. Rev. Immunol. 17 1116-334
12345678910